Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2393)
All Articles published online
|
Mar 15, 2004 (publication date) through May 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chen B, Jin F, Lu P, Lu XL, Wang PP, Liu YP, Yao F, Wang SB. Effect of mitogen-activated protein kinase signal transduction pathway on multidrug resistance induced by vincristine in gastric cancer cell line MGC803. World J Gastroenterol 2004; 10(6): 795-799 [PMID: 15040019 DOI: 10.3748/wjg.v10.i6.795] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i6/795.htm |
| Number | Citing Articles |
| 1 |
H-x Sun, H-w He, S-h Zhang, T-g Liu, K-h Ren, Q-y He, R-g Shao. Suppression of N-Ras by shRNA-expressing plasmid increases sensitivity of HepG2 cells to vincristine-induced growth inhibition. Cancer Gene Therapy 2009; 16(9): 693 doi: 10.1038/cgt.2009.14
|
| 2 |
Shan Zeng, Yiming Tao, Jinlin Huang, Sai Zhang, Liangfang Shen, Huixiang Yang, Haiping Pei, Meizuo Zhong, Gewen Zhang, Ting Liu, Ming Zhou, Hong Shen. WD40 repeat-containing 62 overexpression as a novel indicator of poor prognosis for human gastric cancer. European Journal of Cancer 2013; 49(17): 3752 doi: 10.1016/j.ejca.2013.07.015
|
| 3 |
Xianling Guo, Nannan Ma, Jin Wang, Jianrui Song, Xinxin Bu, Yue Cheng, Kai Sun, Haiyan Xiong, Guocheng Jiang, Baihe Zhang, Mengchao Wu, Lixin Wei. Increased p38-MAPK is responsible for chemotherapy resistance in human gastric cancer cells. BMC Cancer 2008; 8(1) doi: 10.1186/1471-2407-8-375
|
| 4 |
Miroslav Barančík, Vierka Boháčová, Ján Sedlák, Zdenka Sulová, Albert Breier. LY294,002, a specific inhibitor of PI3K/Akt kinase pathway, antagonizes P-glycoprotein-mediated multidrug resistance. European Journal of Pharmaceutical Sciences 2006; 29(5): 426 doi: 10.1016/j.ejps.2006.08.006
|
| 5 |
Alexander A. Shtil*, Janeen Azare†. . International Review of Cytology 2005; 246: 1 doi: 10.1016/S0074-7696(05)46001-5
|
| 6 |
Jian Guan, Xiao-Ping Chen, Hong Zhu, Shun-Feng Luo, Bin Cao, Lei Ding. Involvement of extracellular signal-regulated kinase/mitogen-activated protein kinase pathway in multidrug resistance induced by HBx in hepatoma cell line. World Journal of Gastroenterology 2004; 10(23): 3522-3527 doi: 10.3748/wjg.v10.i23.3522
|
| 7 |
SIYUAN CHEN, YALI WANG, WENWEN RUAN, XIAOMIN WANG, CHAO PAN. Reversing multidrug resistance in hepatocellular carcinoma cells by inhibiting extracellular signal-regulated kinase/mitogen-activated protein kinase signaling pathway activity. Oncology Letters 2014; 8(5): 2333 doi: 10.3892/ol.2014.2521
|
| 8 |
Denglin Chen, Derong Xie, Shuangshuang Guo, Qiong Yang, Zhimin Jiang, Zhuofei Bi, Wen Ma. ERK signaling pathway may induce gemcitabine chemoresistance in pancreatic cancer cell line SW1990 by regulating the expression of mdr-1 and RRM1 gene. The Chinese-German Journal of Clinical Oncology 2009; 8(1): 37 doi: 10.1007/s10330-008-0145-5
|